SCHEMBL29884271

SCHEMBL29884271

CCC1(O)CCc2c(O)c3c(c(O)c2C1OC1CC(N(C)C)C(OC2CC(N(C)C)C(OC4CC(O)C(OC5CCC(OC6CCC(O)C(C)O6)C(C)O5)C(C)O4)C(C)O2)C(C)O1)C(=O)c1cccc(O)c1C3=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.56
MMP2 P08253 2/20 0.56
HTR2B P41595 2/20 0.56
MEN1 O00255 8/20 0.46
KMT2A Q03164 8/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
RECQL P46063 4/20 0.46
USP2 O75604 2/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
HBB P68871 1/20 0.46
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
BLM P54132 6/20 0.41
THRB P10828 6/20 0.41
KDM4E B2RXH2 2/20 0.41
CASP1 P29466 2/20 0.41
HSD17B10 Q99714 1/20 0.41
S100A4 P26447 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453376 0.98 PTGS1 (0.53) PTGS1MMP2HTR2BMEN1KMT2A
Cosmomycin B SCHEMBL29884909 0.97 PTGS1 (0.58) PTGS1MMP2HTR2BMEN1KMT2A
Cosmomycin B SCHEMBL31507007 0.97 PTGS1 (0.58) PTGS1MMP2HTR2BMEN1KMT2A
Cosmomycin C SCHEMBL30610383 0.90 PTGS1 (0.62) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL30864532 0.86 PTGS1 (0.65) PTGS1MMP2HTR2BMEN1KMT2A
Iremycin SCHEMBL30003721 0.85 MEN1 (0.61) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL29885772 0.83 PTGS1 (0.66) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL29884118 0.82 PTGS1 (0.60) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL29885826 0.80 S100A4 (0.56) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL29885946 0.78 MEN1 (0.59) PTGS1MMP2HTR2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed